World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
13554
World Ranking
3921
National Ranking
1526

Richard C. Reichman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard C. Reichman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 135 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard C. Reichman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard C. Reichman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 54 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard C. Reichman is affiliated with the University of Rochester in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with subfields concentrated on Infectious Diseases and Virology.

The scientist's work encompasses topics related to HIV/AIDS, including drug development, treatment, research, and interventions in this area.

Recent scholarly contributions include a paper titled "Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection," published in 2021 in the UNC Libraries venue.

  • Roy M. Gulick
  • Heather J. Ribaudo
  • Cecilia M. Shikuma
  • Stephanie Lustgarten
  • Kathleen Squires

  • UNC Libraries (1 publication)

The research output consists of multiple publications addressing HIV/AIDS drug development and treatment strategies within infectious disease contexts.

Best Publications

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

    Ann C. Collier;Robert W. Coombs;David A. Schoenfeld;Roland L. Bassett

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

    R Dolin;R C Reichman;H P Madore;R Maynard

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

    R C Rose;W Bonnez;R C Reichman;R L Garcea

  • A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome

    Margaret A. Fischl;Corette B. Parker;Carla Pettinelli;Michael Wulfsohn

  • Treatment of Recurrent Genital Herpes Simplex Infections With Oral Acyclovir: A Controlled Trial

    R C Reichman;G J Badger;G J Mertz;L Corey

  • Herpes Zoster-Varicella Infections in Immunosuppressed Patients

    Raphael Dolin;Richard C. Reichman;Mark H. Mazur;Richard J. Whitley

  • Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.

    Roy M. Gulick;Zhaohui Su;Charles Flexner;Michael D. Hughes

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

    S C Dollard;J L Wilson;L M Demeter;W Bonnez

  • A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers

    Thomas G. Evans;William Bonnez;Robert C. Rose;Scott Koenig

  • Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.

    Gregory J. Mertz;Cathy W. Critchlow;Jacqueline Benedetti;Richard C. Reichman

  • Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.

    J. Corwin Vance;Bruce J. Bart;Ronald C. Hansen;Richard C. Reichman

  • Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

    Robert C. Rose;Richard C. Reichman;William Bonnez

  • Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

    Hans J. Woerle;Peter R. Mariuz;Christian Meyer;Richard C. Reichman

  • APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia

    Xia Jin;Andy Brooks;Huiyuan Chen;Ryan Bennett

  • The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

    Paul A. Volberding;Stephen W. Lagakos;Janet M. Grimes;Daniel S. Stein

  • Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults

    Jeffrey M. Jacobson;Michael S. Saag;Melanie A. Thompson;Margaret A. Fischl

  • Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles.

    R C Rose;W Bonnez;C Da Rin;D J McCance

Frequent Co-Authors

Raphael Dolin
Raphael Dolin Beth Israel Deaconess Medical Center
Margaret A. Fischl
Margaret A. Fischl University of Miami
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Alan Forrest
Alan Forrest University at Buffalo, State University of New York
Mark H. Stoler
Mark H. Stoler University of Virginia
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham
Thomas C. Merigan
Thomas C. Merigan Stanford University
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
William G. Powderly
William G. Powderly Washington University in St. Louis
Roy M. Gulick
Roy M. Gulick Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Programs like the fastest and easiest online MPH programs provide a pathway into public health, complementing microbiology knowledge with practical skills in disease prevention and health promotion.

Career options extend beyond traditional lab roles. For instance, becoming a child life specialist salary reflects the demand for professionals supporting children’s emotional and developmental needs in healthcare settings. This role benefits from a background in biological sciences, including microbiology.

Individuals with unique challenges, such as those looking for the best degree for felons, can also find suitable online programs that align with scientific careers. Many institutions now offer accessible options to help rebuild careers legally and responsibly.

Additionally, careers like a functional medicine nurse practitioner can be very rewarding. Exploring the functional medicine nurse salary highlights the financial viability and growing relevance of holistic health roles intertwined with microbiological expertise.

Best Scientists Citing Richard C. Reichman

Trending Scientists

Recently Published Articles